Cubist Systematic Strategies, LLC Gamida Cell Ltd. Transaction History

Cubist Systematic Strategies, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.73 - $2.37 $18,643 - $60,527	25,539 New	25,539 $49,000
Q3 2022 Nov 14, 2022	SELL	$1.53 - $3.39 $18,959 - $42,008	-12,392 Reduced 51.85%	11,510 $18,000
Q2 2022 Aug 15, 2022	BUY	$1.73 - $4.29 $41,350 - $102,539	23,902 New	23,902 $42,000
Q4 2021 Feb 14, 2022	SELL	$2.2 - $4.46 $73,750 - $149,512	-33,523 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.85 - $6.44 $45,510 - $76,127	11,821 Added 54.47%	33,523 $131,000

Q2 2021 Aug 16, 2021	SELL	$5.85 - $8.33 $83,227 - $118,510	-14,227 Reduced 39.6%	21,702 $139,000
Q1 2021 May 17, 2021	BUY	$7.8 - $12.43 $280,246 - $446,597	35,929 New	35,929 $291,000

11.4M

235K

70.5K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.